These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21053587)

  • 1. Recurrent primary hyperphosphatemic tumoral calcinosis: a case report.
    Rangaswamy M; Jayashree K; Saggam P; Vimala MG
    Acta Cytol; 2010; 54(5 Suppl):1003-6. PubMed ID: 21053587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent hyperphosphatemic tumoural calcinosis.
    Amit S; Agarwal A; Nigam A; Rao YK
    BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23010461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperphosphatemic tumoral calcinosis: a 10-year follow-up.
    Alves C; Lima R
    J Pediatr Endocrinol Metab; 2011; 24(1-2):25-7. PubMed ID: 21528811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperphosphatemic tumoral calcinosis.
    Mallick S; Ahmad Z; Gupta AK; Mathur SR
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hyperphosphatemic tumoral calcinosis: a case report.
    Huang J; Cao LG; Zhang TR; Li SM; Meng QQ
    Osteoporos Int; 2022 Jan; 33(1):309-312. PubMed ID: 34245344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic recurrent multifocal osteomyelitis and tumoral calcinosis--is there an association?].
    Maus U; Ihme N; Schroeder S; Andereya S; Ohnsorge JA; Hermanns B; Deutz P; Niedhart C
    Klin Padiatr; 2007; 219(5):277-81. PubMed ID: 17763293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent tumoral calcinosis.
    Nggada HA; Eni UE; Lawan MA; Pindiga UH; Na'aya HU; Khalil MI
    Trop Doct; 2006 Oct; 36(4):240-1. PubMed ID: 17034706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.
    Chakhtoura M; Ramnitz MS; Khoury N; Nemer G; Shabb N; Abchee A; Berberi A; Hourani M; Collins M; Ichikawa S; El Hajj Fuleihan G
    Osteoporos Int; 2018 Sep; 29(9):1987-2009. PubMed ID: 29923062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel
    Zuo Q; Yang W; Liu B; Yan D; Wang Z; Wang H; Deng W; Cao X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():1008800. PubMed ID: 36213261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumoral calcinosis with hyperphosphatemia.
    Mahadevan S; Adhisivam B; Kumar CN
    Indian J Pediatr; 2005 Oct; 72(10):889-90. PubMed ID: 16272668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete resolution of tumoral calcinosis after renal transplantation.
    Miyamoto M; Shibagaki Y; Kimura K
    Urology; 2012 Jun; 79(6):e90-1. PubMed ID: 22516362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massive recurrent tumoral calcinosis: a rare presentation.
    Garg B; Sharma V; Khan SA; Rastogi S
    Acta Orthop Belg; 2011 Jun; 77(3):410-3. PubMed ID: 21846015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspiration biopsy cytology of tumoral calcinosis: a case report.
    Saleh HA; Baker H
    Acta Cytol; 2009; 53(3):323-6. PubMed ID: 19534277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features.
    Dumitrescu CE; Kelly MH; Khosravi A; Hart TC; Brahim J; White KE; Farrow EG; Nathan MH; Murphey MD; Collins MT
    Osteoporos Int; 2009 Jul; 20(7):1273-8. PubMed ID: 18982401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonfamilial hyperphosphatemic tumoral calcinosis with ulnar neuropathy.
    Shetty GM; Murari AS; Shah SV; Dhengle S
    Joint Bone Spine; 2009 Mar; 76(2):198-201. PubMed ID: 19073370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomorphology of tumoral calcinosis: a case report.
    Jassar A; Kumar VK; Kaur K; Bisht A; Mothukuri R
    Indian J Pathol Microbiol; 2007 Jul; 50(3):619-21. PubMed ID: 17883163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperphosphatemic tumoral calcinosis.
    Savaci N; Avunduk MC; Tosun Z; Hoşnuter M
    Plast Reconstr Surg; 2000 Jan; 105(1):162-5. PubMed ID: 10626985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumoral calcinosis, a clinical report of eleven cases.
    Noyez JF; Murphree SM; Chen K
    Acta Orthop Belg; 1993; 59(3):249-54. PubMed ID: 8237339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate.
    Emecen Sanli M; Kilic A; Aktasoglu E; Inci A; Okur I; Ezgu F; Tumer L
    J Pediatr Endocrinol Metab; 2021 Jun; 34(6):813-816. PubMed ID: 33819418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
    Lammoglia JJ; Mericq V
    Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.